Frontiers in pain research (Lausanne, Switzerland)
2026
Birgit Heckemann, Lionel Snell, Mark I Johnson
This perspectives article explores magical thinking (which is often dismissed as irrational or pathologized) as a potentially valuable personal orientation and resource for people living with chronic pain: as a way to make more sense of their complex and challenging life experience, psychologically as well as socially. Magical thinking entails a broader acceptance of connectivity between...
Frontiers in pain research (Lausanne, Switzerland)
2023
Carole A Paley, Mark I Johnson
3 citations
In this article, we provide a unique perspective on the use of mindfulness interventions in a whole health framework embedded within the theory of salutogenesis and the concept of painogenic environments. We argue that mindfulness is a valuable tool to bridge exploration of inner experiences of bodily pain with socio-ecological influences on thoughts and emotions. We outline research from...
Journal of Neurophysiology
October 1, 2022
Don M Tucker, Phan Luu, Mark I Johnson
16 citations
Neurophysiological mechanisms are increasingly understood to constitute the foundations of human conscious experience. These include the capacity for ongoing memory, achieved through a hierarchy of reentrant cross-laminar connections across limbic, heteromodal, unimodal, and primary cortices. The neurophysiological mechanisms of consciousness also include the capacity for volitional direction...
The Oxford Handbook of 4E Cognition
October 9, 2018
Mark I Johnson
Abstract Analytic philosophy of language was originally based on a fundamentally disembodied view of meaning and language. In contrast, research in cognitive linguistics and neuroscience emphasizes the central role of the body and brain in shaping meaning, concepts, and thought. Meaning is not, in the first instance, linguistic. Instead, language depends on and recruits prior sensory, motor,...
Pain Management
May 1, 2018
Andy Whelan, Mark I Johnson
51 citations
Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety and fear of death in terminal illness. The aim of this review is to discuss the potential use of LSD and psilocybin for patients with persistent pain. LSD and psilocybin are 5-hydroxytryptamine receptor agonists and may interact with nociceptive and antinociceptive processing. Tentative...